CRDL Stock Analysis: Buy, Sell, or Hold?
CRDL - Cardiol Therapeutics Inc. Class A Common Shares
$1.10
0.05 (4.76%)
▲
5d:
+5.77%
30d:
-1.79%
90d:
-21.99%
BUY
HIGH Confidence
Analysis Updated: Jul 6, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When CRDL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CRDL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CRDL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CRDL is currently trading at $1.10, which is considered fair relative to its 30-day fair value range of $1.02 to $1.15.
Technical Outlook: Technically, CRDL is in a uptrend. Immediate support is located at $1.02, while resistance sits at $1.18. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: CRDL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.13 (+578.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CRDL is in a uptrend. Immediate support is located at $1.02, while resistance sits at $1.18. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: CRDL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.13 (+578.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.02 -
$1.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 578.9% below Wall St target ($7.13)
Trading Range Analysis
30-Day Trading Range
$1.02 -
$1.15
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.02
Resistance Level
$1.18
Current Trend
Uptrend
Technical data as of
Jun 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.75
Wall Street Target
$7.13
(+578.9%)
Share & Embed Analysis
Last updated: July 06, 2026 2:32 PM ET
Data refreshes hourly during market hours. Next update: 3:32 PM
Data refreshes hourly during market hours. Next update: 3:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$196 | 67 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 59 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$118 | 56 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$41 | 64 BUY |
